Application 209970

Type: ANDA
Sponsor: TEVA PHARMS USA INC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	MESALAMINE	MESALAMINE	CAPSULE, EXTENDED RELEASE;ORAL	375MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A209970-001	MESALAMINE	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL			2022-05-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	2022-05-06	`5c6f7cd8ea54…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	2022-05-06	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	2022-05-06	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	2022-05-06	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	2022-05-06	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A209970-001	MESALAMINE	375MG	CAPSULE, EXTENDED RELEASE / ORAL		2022-05-06	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209970-001	AB	1	`5c6f7cd8ea54…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A209970-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A209970-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A209970-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A209970-001	AB	1	`cb3db0bc1861…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 4 · 65 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
APRISO	MESALAMINE	Salix Pharmaceuticals, Inc.	7951139c-b271-45a4-b523-34b23800917b	2026-08-27	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Rowasa	MESALAMINE	Viatris Specialty LLC	e505ab99-1943-4216-a178-4d5dbe64e3b2	2026-08-03	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
mesalamine	MESALAMINE	Major Pharmaceuticals	14ac4435-903b-41f5-a3c4-8c73de3e4cef	2026-07-27	Warnings, Adverse reactions	Name fallback brand name: mesalamine generic name: MESALAMINE
mesalamine	MESALAMINE	Zydus Pharmaceuticals USA Inc.	ad8c7930-92e2-4372-a874-da22b9ae333e	2026-07-14	Warnings, Adverse reactions	Name fallback brand name: mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	Sandoz Inc	47b5d1ee-b439-4ccb-9b01-c0875ccd748a	2026-06-30	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	Nuvaila Limited	875d573f-99a1-426a-8321-4d511690d503	2026-06-03	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	ANI Pharmaceuticals, Inc.	485ed763-976e-4410-a401-7ff762a931b3	2026-05-20	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
MESALAMINE	MESALAMINE	KLM Laboratories Private Limited	54cfed92-5e28-4a4d-a70f-2a60b5b54c12	2026-04-01	Warnings, Adverse reactions	Name fallback brand name: MESALAMINE generic name: MESALAMINE
Lialda	MESALAMINE	Takeda Pharmaceuticals America, Inc.	3098a080-be86-4265-9818-7fc4beab77b7	2026-03-24	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Golden State Medical Supply, Inc.	4c4ffb68-3ca4-35cd-e063-6294a90ab929	2026-03-05	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	Actavis Pharma, Inc.	73317da3-cba0-4106-9e88-79b0e2f642af	2026-02-24	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	AvKARE	22f3ee49-ac57-84f5-e063-6394a90aae91	2026-01-14	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	Chartwell RX, LLC	9703f92d-1d15-4376-8b2b-51502c266012	2025-12-17	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
MESALAMINE	MESALAMINE	Camber Pharmaceuticals, Inc.	ef471372-8d9f-4d95-9371-44522c69058f	2025-12-10	Warnings, Adverse reactions	Name fallback brand name: MESALAMINE generic name: MESALAMINE
Mesalamine	MESALAMINE	Rising Pharma Holdings, Inc.	c26ae6cb-041b-4cfc-90ca-c4e1cb23458c	2025-12-10	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	Ingenus Pharmaceuticals, LLC	58503afe-b8d4-4710-a194-e3acd64ecf1f	2025-12-05	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	Upsher-Smith Laboratories, LLC	1e6978d0-01db-477d-a90f-27561777480f	2025-12-01	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	Encube Ethicals, Inc.	d6b68275-b2a4-4965-9862-cf14acf8c599	2025-10-07	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	Teva Pharmaceuticals USA, Inc.	6fd0a906-e1b5-4238-a79b-a195510ddc84	2025-05-30	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE
Mesalamine	MESALAMINE	American Health Packaging	e638681d-8fca-4bf8-a1fb-8e52357a64da	2025-05-21	Warnings, Adverse reactions	Name fallback brand name: Mesalamine generic name: MESALAMINE